Literature DB >> 14705844

Comparison of the fatal toxicity index of zopiclone with benzodiazepines.

David M Reith1, John Fountain, Rebecca McDowell, Murray Tilyard.   

Abstract

BACKGROUND: Zopiclone is a hypnosedative structurally unrelated to the benzodiazepines but operating at the same receptor complex. Although zopiclone has been used in clinical practice for many years, relatively little is known of its relative toxicity in comparison with other hypnosedatives.
METHOD: Deaths, where hypnosedatives were implicated, in New Zealand (NZ) in 2001 were identified from a chemical injury database. Prescription and aggregate defined daily dose (DDD) data forNZ in 2001 were obtained from a national prescribing database. Rates of death per prescription and DDD, and relative rates between individual hypnosedatives and benzodiazepines, and their respective 95% CI were calculated.
RESULTS: Of the 200 poisoning deaths in NZ for 2001, 39 involved hypnosedatives, and zopiclone was involved in 12. Hypnosedatives were the sole agents in only one death and were the primary agents in eight deaths. Zopiclone was the sixth most commonly involved agent in poisoning deaths in NZ in 2001. The relative rate of death per prescription (95% CI) and DDD (95% CI) of zopiclone compared with benzodiazepines were 1.04 (0.49-2.05) and 0.59 (0.28-1.16), respectively. The relative rates of death per DDD (95% CI) for alprazolam and chlormethiazole compared with the other sedatives/anxiolytics were 6.2 (1.6-17.0) and 20.9 (2.5-79.8) respectively.
CONCLUSIONS: The fatal toxicity for zopiclone was not significantly different from that for benzodiazepines as a group when adjusted for usage, whereas alprazolam and chlormethiazole had greater toxicity. Hypnosedatives are contributory factors rather than primary substances in poisoning deaths.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14705844     DOI: 10.1081/clt-120026520

Source DB:  PubMed          Journal:  J Toxicol Clin Toxicol        ISSN: 0731-3810


  9 in total

1.  Carisoprodol intoxications: a retrospective study of forensic autopsy material from 1992-2003.

Authors:  Gudrun Høiseth; Jørgen G Bramness; Asbjørg S Christophersen; Jørg Mørland
Journal:  Int J Legal Med       Date:  2006-11-18       Impact factor: 2.686

2.  The relative lethal toxicity of pharmaceutical and illicit substances: A 16-year study of the Greater Newcastle Hunter Area, Australia.

Authors:  Jonathan Brett; Claire E Wylie; Jacques Raubenheimer; Geoff K Isbister; Nick A Buckley
Journal:  Br J Clin Pharmacol       Date:  2019-07-17       Impact factor: 4.335

3.  Fatal poisonings in Oslo: a one-year observational study.

Authors:  Mari A Bjornaas; Brita Teige; Knut E Hovda; Oivind Ekeberg; Fridtjof Heyerdahl; Dag Jacobsen
Journal:  BMC Emerg Med       Date:  2010-06-06

Review 4.  Alprazolam is relatively more toxic than other benzodiazepines in overdose.

Authors:  Geoffrey K Isbister; Luke O'Regan; David Sibbritt; Ian M Whyte
Journal:  Br J Clin Pharmacol       Date:  2004-07       Impact factor: 4.335

Review 5.  The clinical and forensic toxicology of Z-drugs.

Authors:  Naren Gunja
Journal:  J Med Toxicol       Date:  2013-06

6.  Nonmedical Use of Antihistaminergic Anxiolytics and Other Prescription Drugs among Persons with Opioid Dependence.

Authors:  Disa Dahlman; Tove Abrahamsson; Alex H Kral; Anders Hakansson
Journal:  J Addict       Date:  2016-12-20

7.  An Insight into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions.

Authors:  Fabrizio Schifano; Stefania Chiappini; John M Corkery; Amira Guirguis
Journal:  Int J Neuropsychopharmacol       Date:  2019-04-01       Impact factor: 5.176

8.  Alprazolam-related deaths in Scotland, 2004-2020.

Authors:  John Martin Corkery; Amira Guirguis; Stefania Chiappini; Giovanni Martinotti; Fabrizio Schifano
Journal:  J Psychopharmacol       Date:  2022-08-01       Impact factor: 4.562

9.  A 3-year survey quantifying the risk of dose escalation of benzodiazepines and congeners to identify risk factors to aid doctors to more rationale prescribing.

Authors:  Ingunn Fride Tvete; Trine Bjørner; Ivar Andreas Aursnes; Tor Skomedal
Journal:  BMJ Open       Date:  2013-10-04       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.